A5021724884- Orthopedic Infections and Treatments
- Diabetic Foot Ulcer Assessment and Management
- Infectious Diseases and Tuberculosis
- Orthopaedic implants and arthroplasty
- Infective Endocarditis Diagnosis and Management
- Wound Healing and Treatments
- Streptococcal Infections and Treatments
- Antimicrobial Resistance in Staphylococcus
- Surgical site infection prevention
- Total Knee Arthroplasty Outcomes
- Infectious Aortic and Vascular Conditions
- Bacterial Identification and Susceptibility Testing
- Antibiotics Pharmacokinetics and Efficacy
- Hematological disorders and diagnostics
- Mycobacterium research and diagnosis
- Antifungal resistance and susceptibility
- Antibiotic Resistance in Bacteria
- Skin Diseases and Diabetes
- Peripheral Artery Disease Management
- Healthcare Systems and Practices
- Diagnosis and treatment of tuberculosis
- Pressure Ulcer Prevention and Management
- Tuberculosis Research and Epidemiology
- Antibiotic Use and Resistance
- Rheumatoid Arthritis Research and Therapies
Centre Hospitalier de Tourcoing
2016-2025
Université de Lille
2015-2025
Centre Hospitalier Universitaire de Lille
2012-2024
Hôpital Roger Salengro
2012-2024
Evaluation des technologies de santé et des pratiques médicales
2011-2024
Université Lille Nord de France
2011-2024
Société Francophone du Diabète
2024
Weatherford College
2013-2020
Hôpital Joseph-Ducuing
2018-2019
Lille’s Cardiology Hospital
2019
Abstract The International Working Group on the Diabetic Foot (IWGDF) has published evidence‐based guidelines prevention and management of diabetic foot disease since 1999. This guideline is diagnosis treatment infection in persons with diabetes updates 2015 IWGDF guideline. On basis patient, intervention, comparison, outcomes (PICOs) developed by committee, conjunction internal external reviewers consultants, systematic reviews committee conducted (new) (updated from 2015), we offer 27...
Recommendations Classification/diagnosis Diabetic foot infection must be diagnosed clinically, based on the presence of local or systemic signs symptoms inflammation (strong; low). Assess severity any diabetic using Infectious Diseases Society America/International Working Group Foot classification scheme moderate). Osteomyelitis For an infected open wound, perform a probe‐to‐bone test; in patient at low risk for osteomyelitis, negative test largely rules out diagnosis, while high‐risk...
Multiple disciplines are involved in the management of diabetic foot disease, and a common vocabulary is essential for clear communication. Based on systematic reviews literature that form basis International Working Group Diabetic Foot (IWGDF) Guidelines, IWGDF has developed set definitions criteria disease. This document describes these criteria. We suggest be used consistently both clinical practice research to facilitate communication between professionals.
Abstract Diabetes‐related foot disease results in a major global burden for patients and the healthcare system. The International Working Group on Diabetic Foot (IWGDF) has been producing evidence‐based guidelines prevention management of diabetes‐related since 1999. In 2023, all IWGDF Guidelines have updated based systematic reviews literature formulation recommendations by multidisciplinary experts from over world. addition, new guideline acute Charcot neuro‐osteoarthropathy was created....
The management of prosthetic joint infection usually consists a combination surgery and antimicrobial therapy. appropriate duration therapy for this indication remains unclear.
Abstract Multiple disciplines are involved in the management of diabetes‐related foot disease and a common vocabulary is essential for clear communication. Based on systematic reviews literature that form basis International Working Group Diabetic Foot (IWGDF) Guidelines, IWGDF has developed set definitions criteria disease. This document describes 2023 update these criteria. We suggest be used consistently both clinical practice research, to facilitate communication with people between...
Abstract The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines management and prevention of diabetes-related foot diseases since 1999. present guideline is an update 2019 IWGDF diagnosis infections in persons with diabetes mellitus. Grading Recommendations, Assessment, Development, Evaluation (GRADE) framework was used for development this guideline. This structured around identifying clinically relevant questions P(A)ICO format, determining...
Background. We assessed the diagnostic value of swab cultures by comparing them with corresponding percutaneous bone biopsy specimens for patients diabetic foot osteomyelitis.
The purpose of this article was to identify criteria predictive remission in nonsurgical treatment diabetic foot osteomyelitis.Diabetic patients who were initially treated without orthopedic surgery for osteomyelitis the toe or metatarsal head a nonischemic between June 2002 and 2003 nine French centers identified, their medical records reviewed. Remission defined as absence any sign infection at initial contiguous site assessed least 1 year after end treatment. A total 24 demographic,...
OBJECTIVE Little is known about the optimal duration of antibiotic therapy for diabetic foot osteomyelitis (DFO). This study sought to compare effectiveness 6 versus 12 weeks in patients with DFO treated nonsurgically (i.e., antibiotics alone). RESEARCH DESIGN AND METHODS was a prospective randomized trial comparing 6- 12-week treatment. Remission during monitoring period defined as complete and persistent (>4 weeks) healing wound (if present initially), absence recurrent infection at...
Background. Needle puncture has been suggested as a method for identifying bacteria in the bones patients with diabetes osteomyelitis of foot. However, no studies have compared needle concomitant transcutaneous bone biopsy, which is current standard recommended international guidelines. Methods. We conducted prospective study 2 French foot clinics. Transcutaneous biopsy specimens, and swab samples were collected on same day each patient. Results. Overall, 31 included from July 2006 through...
Fracture-related infection (FRI) is a major complication in musculoskeletal trauma and one of the leading causes morbidity. Standardization general treatment strategies for FRI has been poor. One reasons heterogeneity this patient population, including various anatomical locations, multiple fracture patterns, different degrees soft-tissue injury, conditions. This variability makes complex hard to standardize. As these infections are biofilm-related, surgery remains cornerstone treatment,...
Dalbavancin is a lipoglycopeptide with long elimination half-life and currently licensed for the treatment of acute bacterial skin structure infections in adults. Dalbavancin's potential treating off-label complex Gram-positive promising real-world experience such growing. However, clear guidance on extended dosing regimens lacking.This study aimed to provide expert opinion based recent pharmacokinetic literature infection areas that require > 2 weeks treatment.A single face-to-face meeting...